Los Vascos, Grande Réserve Colchagua

Los Vascos, Grande Réserve

Colchagua

I've managed to put in my luggage 3 bottles of red wine on my last trip to South America for ending the year in this spectacular continent! Like most Chilean Cabernet Sauvignon wines it has a very nice taste and I would definately recommend everyone to give it a try but I don't think that I would be carrying it once more all the way to Istanbul! I've paid around 12USD for the bottle and I have to admit that great value for money!

The Grande Réserve is a benchmark for elegance and finesse in Chile. The wine is a blend of mainly Cabernet Sauvignon and is produced using traditional vinification and maturing techniques.

The wine is characterized by the complexity and persistence of its bouquet of cherries and blackcurrants (Cabernet Sauvignon), strawberries (Malbec), raspberries (Syrah) and plums, with notes of bay leaves and black pepper (Carmenère). A delicious, exciting wine, with great density and harmony.

Vintage 2009

From flowering onwards, the 2009 vintage experienced favourable weather conditions suited to optimal production. The rains were concentrated in the autumn and winter, in quantities close to the averages for the valley. The heat in the early spring was conducive to the buds opening and to the vines developing with controlled vigour. Temperature variations brought beautiful colour, intense fruit aromas and good quality tannins. The grapes ripened in ideal conditions through to the harvests.

Deep ruby red colour. Complex fruity nose, ripe cherries and blackberries, firm figs and notes of cedar, tobacco, cinnamon, white pepper, mint and bitter chocolate. Well-structured on the palate, offering remarkable balance, volume and consistency. A wine to be enjoyed alone or with friends, while reading a good book or simply for the pleasure of drinking a fine wine.

Grape varieties:

Cabernet Sauvignon, Carménère, Syrah, Malbec.

Length of ageing in oak barrels:

12 months, including 50% in new barrels.

Average annual production:

60 000 to 80 000 cases.